Perspective
Rob Merrill,
CEO,
6th,
2026
Where approvals, AI output and agency execution drift apart, and how one approved record closes the gap.
Your MLR team approves a claim. A month later, four versions of it are in market. One agency still has the old safety language. A publisher quietly “fixed” a line. And your new AI content tool has just produced a fifth version that nobody has reviewed.
Nobody planned it. It’s what happens when review and execution live in different worlds, and AI makes it happen faster.
ChatGPT and Perplexity are talking about your drugs too. You can’t govern them. You can govern everything your company, and everyone working for it, puts out. That’s where the real exposure sits.
FDA is watching again
For years, enforcement was quiet: five OPDP letters in 2023, five in 2024. Then, in September 2025, nearly 100 went out in a single week. The pace has continued into 2026, and FDA says it now uses AI to monitor drug ads.
The standard hasn’t changed: fair balance, required risk information, consistency with FDA-required labeling. What’s changed is how closely someone is checking.
Close the loop around the approved record
Keep one approved record at the center, and govern every point where content leaves it.
Gate before release. Before any AI-assisted output goes public, it has to answer one question: is this system allowed to act? An AI tool might be allowed to sort incoming inquiries but not to publish a response. Publishing takes a label check and a human sign-off. If an output misses a boxed warning, or treats patient-forum chatter as evidence, it’s held and sent to Medical, Legal and Regulatory (MLR) review.
Watch what goes live. Approval isn’t the finish line. Monitor live channels (web, paid social, display, partner sites, influencers) against the approved record, so changes show up on the asset itself, not at the next audit.
Feed it back. Whatever turns up in market goes back into claims, briefs and approval checks. The same mistake shouldn’t get approved twice.
Why legal and regulatory should care
Once you know, or should have known, that your own content is drifting, the question becomes what you did next. The record shows it.
Promotional material doesn’t expire at launch, and neither does scrutiny. This year’s campaign can become next year’s question, long after the team has moved on. So the trail has to be there the whole time: what was said, what supported it, who approved it, what was held, what audiences actually saw, and what happened when a problem surfaced. Build it as you go. Don’t reconstruct it after a letter arrives.
Bottom line
This isn’t about faster approvals. It’s about closing the gap where approvals, AI output and agency execution drift apart. That’s where the rework, the risk and the lost time hide.
One approved record. Both sides of the handoff. For as long as the work is out there.
Want to see where your handoffs break? Let’s talk.